Table 2.
Insulin dose and dosing frequency at pre-study, baseline and week 24
| Insulin regimen at week 24 | |||
|---|---|---|---|
| Aspart alone | Aspart premix | Aspart + basal | |
| Insulin dose (U/day) | |||
| n | 1,545 | 1,379 | 214 |
| Pre-study | 33.0 (18.5) | 34.8 (16.4) | 39.6 (23.6) |
| Baseline | 27.5 (13.5) | 30.3 (12.0) | 26.3 (14.1) |
| Week 24 | 28.0 (13.3) | 28.6 (13.1) | 49.1 (22.3) |
| Insulin dose by body weight (U/kg/day) | |||
| n | 1,468 | 1,347 | 199 |
| Pre-study | 0.49 (0.28) | 0.50 (0.24) | 0.57 (0.32) |
| Baseline | 0.42 (0.22) | 0.44 (0.18) | 0.40 (0.22) |
| Week 24 | 0.43 (0.21) | 0.42 (0.19) | 0.72 (0.29) |
| Daily dose frequency | |||
| Pre-study, n (%) | 423 | 332 | 125 |
| Once | 89 (21.0) | 63 (19.0) | 39 (31.2) |
| Twice | 201 (47.5) | 205 (61.7) | 44 (35.2) |
| Thrice | 102 (24.1) | 40 (12.0) | 22 (17.6) |
| >Thrice | 31 (7.3) | 24 (7.2) | 20 (16.0) |
| Baseline, n (%) | 1,545 | 1,378 | 213 |
| Once | 98 (6.3) | 59 (4.3) | 24 (11.3) |
| Twice | 592 (38.3) | 380 (27.6) | 19 (8.9) |
| Thrice | 802 (51.9) | 807 (58.6) | 154 (72.3) |
| >Thrice | 53 (3.4) | 132 (9.6) | 16 (7.5) |
| Week 24, n (%) | 1,544 | 1,379 | 214 |
| Once | 94 (6.1) | 63 (4.6) | 0 |
| Twice | 641 (41.5) | 1,181 (85.6) | 17 (7.9) |
| Thrice | 767 (49.7) | 132 (9.6) | 24 (11.2) |
| >Thrice | 42 (2.7) | 3 (0.2) | 173 (80.8) |
Data are mean (SD), or as stated